Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
A Dose-escalation Study to Evaluate the Safety and Clinical Activity of PBCAR269A, With or Without Nirogacestat, in Study Participants With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04171843. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function
ClinicalTrials.gov study NCT00118170. IPD Sharing: Not stated. Countries: 1. Publications: 0.
68Ga-pentixather and 68Ga-pentixafor PET/CT in Multiple Myeloma
ClinicalTrials.gov study NCT05364177. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetics of Lenalidomide (Revlimid®) in Patients With Multiple Myeloma and Impaired Renal Function
ClinicalTrials.gov study NCT00779922. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma
ClinicalTrials.gov study NCT04756726. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
ClinicalTrials.gov study NCT03607643. IPD Sharing: NO. Countries: 1. Publications: 0.
Carfilzomib and Dexamethasone in Treating Patients With Multiple Myeloma Who Previously Underwent a Stem Cell Transplant
ClinicalTrials.gov study NCT01812720. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prevalence of Monoclonal Gammopathy of Undetermined Significance (MGUS) / Multiple Myeloma (MM) Among Unique Populations of Black People
ClinicalTrials.gov study NCT06472830. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse
ClinicalTrials.gov study NCT06827860. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma
ClinicalTrials.gov study NCT04722146. IPD Sharing: YES. Countries: 5. Publications: 0.
Study of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior Year
ClinicalTrials.gov study NCT00424983. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Zn-DDC to Target Hypoxia-NFkappaB-CSCs Pathway in Multiple Myeloma
ClinicalTrials.gov study NCT04234022. IPD Sharing: NO. Countries: 1. Publications: 0.
The Burden of Multiple Myeloma on Patients and Caregivers Quality of Life: a Canadian Real-World Study
ClinicalTrials.gov study NCT06610045. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy and Safety of HLX15-IV Versus DARZALEX® in Combination with Lenalidomide-Dexamethasone (Rd) in Transplant-ineligible Patients with Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT06895512. IPD Sharing: NO. Countries: 1. Publications: 0.
Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT00337506. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM)
ClinicalTrials.gov study NCT06087653. IPD Sharing: NO. Countries: 1. Publications: 0.
Dasatinib in Combination With Melphalan and Prednisone to Treat Relapsed and Refractory Multiple Myeloma Patients
ClinicalTrials.gov study NCT01116128. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluating the Efficacy and Safety of the Lower Dose of Bortezomib Plus Busulfan and Melphalan as a Conditioning Regimen in Patients With Multiple Myeloma Undergoing Autologous Peripheral Blood Stem C
ClinicalTrials.gov study NCT01255527. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Efficacy and Safety Study of Bortezomib Re-treatment in Multiple Myeloma
ClinicalTrials.gov study NCT00431769. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Phase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06105554. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.